Pathogenic mechanisms of fibromyalgia
- PMID: 12039441
- DOI: 10.1016/s1568-1637(01)00004-6
Pathogenic mechanisms of fibromyalgia
Abstract
The symptomatology characterizing fibromyalgia comprises three systems: the musculoskeletal system with widespread muscular pain, neuroendocrine disorders, and psychological distress including anxiety and depression. Fibromyalgia is predominantly found in middle aged women. Though the most prominent symptom of fibromyalgia is pain in defined regions of the locomotor system, the numerous other somatoform and psychological disorders suppose a common primary disturbance which is considered to originate within higher levels of the central nervous system. Studies of the entire endocrine profile of fibromyalgia patients support the hypothesis that an elevated activity of corticotropin releasing hormone (CRH) neurons determines not only many symptoms of fibromyalgia but may also cause alterations observed in the hormonal axes. Hypothalamic CRH neurons thus may play a key role not only in resetting the various endocrine loops but possibly also nociceptive and psychological mechanisms as well
Similar articles
-
Hormonal pertubations in fibromyalgia syndrome.Ann N Y Acad Sci. 1999 Jun 22;876:325-38; discussion 339. doi: 10.1111/j.1749-6632.1999.tb07657.x. Ann N Y Acad Sci. 1999. PMID: 10415628 Review.
-
Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients.Scand J Rheumatol Suppl. 2000;113:8-12. Scand J Rheumatol Suppl. 2000. PMID: 11028824 Review.
-
Neuroendocrine abnormalities in fibromyalgia.Curr Pain Headache Rep. 2002 Aug;6(4):289-98. doi: 10.1007/s11916-002-0050-5. Curr Pain Headache Rep. 2002. PMID: 12095464 Review.
-
The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia.Med Hypotheses. 1995 May;44(5):369-78. doi: 10.1016/0306-9877(95)90263-5. Med Hypotheses. 1995. PMID: 8583967 Review.
-
Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.Best Pract Res Clin Rheumatol. 2001 Dec;15(5):747-58. doi: 10.1053/berh.2001.0191. Best Pract Res Clin Rheumatol. 2001. PMID: 11812019 Review.
Cited by
-
Alteration of serotonin transporter density and activity in fibromyalgia.Arthritis Res Ther. 2006;8(4):R99. doi: 10.1186/ar1982. Arthritis Res Ther. 2006. PMID: 16790074 Free PMC article.
-
A comparison of quality of life, demographic and clinical characteristics of Brazilian men with fibromyalgia syndrome with male patients with depression.Rheumatol Int. 2010 Feb;30(4):473-8. doi: 10.1007/s00296-009-0994-4. Epub 2009 Jun 27. Rheumatol Int. 2010. PMID: 19562343
-
Fear-learning deficits in subjects with fibromyalgia syndrome?Eur J Pain. 2013 Oct;17(9):1374-84. doi: 10.1002/j.1532-2149.2013.00300.x. Epub 2013 Mar 7. Eur J Pain. 2013. PMID: 23468076 Free PMC article.
-
Subjective Sleep Quality Versus Objective Accelerometric Measures of Sleep and Systemic Concentrations of Sleep-Related Hormones as Objective Biomarkers in Fibromyalgia Patients.Biomedicines. 2023 Jul 13;11(7):1980. doi: 10.3390/biomedicines11071980. Biomedicines. 2023. PMID: 37509619 Free PMC article.
-
Genital sympathetic skin responses in fibromyalgia syndrome.Rheumatol Int. 2006 Sep;26(11):1025-30. doi: 10.1007/s00296-006-0131-6. Epub 2006 Apr 20. Rheumatol Int. 2006. PMID: 16625337
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical